Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 8765154, 11 pages
https://doi.org/10.1155/2017/8765154
Review Article

Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy

1Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
2Institute for Integrated Cell Material Sciences (iCeMS), Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku, Kyoto 606-8507, Japan

Correspondence should be addressed to Akitsu Hotta; pj.ca.u-otoyk.aric@attoh.ustika

Received 24 January 2017; Revised 23 March 2017; Accepted 28 March 2017; Published 18 May 2017

Academic Editor: Masatoshi Suzuki

Copyright © 2017 Peter Gee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Peter Gee, Huaigeng Xu, and Akitsu Hotta, “Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy,” Stem Cells International, vol. 2017, Article ID 8765154, 11 pages, 2017. https://doi.org/10.1155/2017/8765154.